MedTrace Logo

Genome Analysis Across Populations in Inflammatory Bowel Disease

NCT06042387 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-03-25

No results posted yet for this study

Summary

Objective:

To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

Conditions

Interventions

GENETIC

Blood or saliva sample collection

Blood or saliva sample \& clinical data collection

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Mount Sinai Hospital, Canada

    lead OTHER

Principal Investigators

  • Mark Silverberg, MD PhD · Sinai Health System

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2027-05-31
Completion
2027-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06042387 on ClinicalTrials.gov